Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, pharmacokinetics and efficacy of bimagrumab in overweight/obese patients with type 2 diabetes has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bimagrumab (bimagrumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2020-06-04